Harmony Biosciences Holdings (HRMY) EBT (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.63% |
| Dec 31, 2025 | -39.61% |
| Sep 30, 2025 | 35.97% |
| Jun 30, 2025 | -13.19% |
| Mar 31, 2025 | 1.82% |
| Dec 31, 2024 | -9.68% |
| Sep 30, 2024 | 186.58% |
| Jun 30, 2024 | -58.11% |
| Mar 31, 2024 | 30.48% |
| Dec 31, 2023 | -23.43% |
| Sep 30, 2023 | 17.55% |
| Jun 30, 2023 | 16.72% |
| Mar 31, 2023 | -14.34% |
| Dec 31, 2022 | 453.57% |
| Sep 30, 2022 | -72.74% |
| Jun 30, 2022 | 25.00% |
| Mar 31, 2022 | -4.45% |
| Dec 31, 2021 | 332.61% |
| Sep 30, 2021 | -165.40% |
| Jun 30, 2021 | 117.83% |
| Mar 31, 2021 | 3,650.96% |
| Dec 31, 2020 | -110.90% |
| Sep 30, 2020 | 7,170.37% |
| Jun 30, 2020 | 99.93% |
| Mar 31, 2020 | -5.98% |
| Dec 31, 2019 | -14.24% |